1:09
Treating GvHD: current challenges and newly approved drugs
Katie Gatwood
1:43
The importance of pharmacist intervention in the treatment of GvHD with ruxolitinib and ibrutinib
Katie Gatwood
2:29
Ruxolitinib and ibrutinib: the future for GvHD treatment?
Katie Gatwood
1:29
The introduction of biosimilar rituximab: a case study from the pharmacist’s perspective
Simon Cheesman
4:02
Improving the Cancer Journey: update and the role of pharmacists
Trisha Hatt
1:54
Improving the NICE drug approval process
Man-Chie Chow
1:58
The importance of BOPA
Islam Elkonaissi
1:53
The introduction of novel immunotherapies and the pharmacist
Islam Elkonaissi
1:29
The CRUK Facilitator programme and NHS Lanarkshire pharmacists
Gillian Phillips
1:54
The CRUK Facilitator programme: collaborating with pharmacists
Gillian Phillips
0:57
How pharmacists and patients can effectively use Macmillan Cancer Support
Fiona Smith
2:19
How services outside of primary and secondary care settings can help cancer patient’s treatment
Fiona Smith
1:01
BOPA 2017: What are the hot topics?
Carl Booth
2:30
Selecting the best abstracts for presentation at BOPA
Carl Booth
1:47
Driving efficiency improvements in the NHS
Bryn Thomas
3:33
The developing role of pharmacist prescribers
Bryn Thomas
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals